Investor Relations Home

Accuray Incorporated is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.

Accuray does not assume a duty to update information on this website, except through the normal quarterly financial press releases and regulatory filings.

ARAY (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.08 (2.00%)
Data as of Aug 17, 2017 11:07 a.m. ET
Refresh quote
Stock chart for: ARAY.O.  Currently trading at $4.08 with a 52 week high of $6.39 and a 52 week low of $3.85.
Data provided by Nasdaq. Minimum 15 minutes delayed.
Webcast ImageWebcast
Q4 2017 Accuray Incorporated Earnings Conference Call (Live)
Aug 22, 2017 at 1:30 p.m. PT
Q4 2017 Accuray Incorporated Earnings Conference Call
Tuesday, August 22, 2017 1:30 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast

Press Releases

Summit Cancer Center-Boise Treats Its First Cancer Patients Using the Accuray Radixact™ System
Freestanding Center is First in the Western U.S. to Treat Patients with this "Smart" Radiation Therapy Delivery System with Fully-Integrated Treatment Planning and Data Management Systems SUNNYVALE, Calif., Aug. 17, 2017 /PRNewswire/ -- Accuray ... 
Aug 17, 2017
Accuray To Report Fiscal 2017 Fourth Quarter And Full Year Results On August 22, 2017
SUNNYVALE, Calif., Aug. 14, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2017 ended June 30, 2017 on Tuesday, August 22, 2017 after the market close. Management will host a confer... 
Aug 14, 2017

Upcoming Investor Event

Some documents in the Investor Relations section require that you have Adobe Acrobat Reader® installed in order to view files in PDF format. Download the newest version of Acrobat Reader